论文部分内容阅读
目的对已在有关胰腺文献有记载的存在于呼吸道的囊性纤维化跨膜传导调节因子(CFTR)基因类型进行评估。材料与方法本研究经伦理委员会审查通过并遵循HIPAA要求,不需要签署知情同意书。93例病人通过胸片和肺功能测试(PFT)来评估基因类型的作用。反复对一系列的胸片和肺功能测试[预计第1s
OBJECTIVE: To evaluate the type of cystic fibrosis transmembrane conductance regulator (CFTR) gene that has been documented in the relevant literature of the pancreas in the respiratory tract. Materials and Methods The study was reviewed by ethical committees and followed HIPAA requirements without the need to sign an informed consent form. Ninety-three patients were assessed for genotype by chest radiograph and pulmonary function test (PFT). Repeatedly on a series of chest radiographs and lung function tests [Expected 1sts